Study shows Diachrome improves blood sugar control in people with type 2 diabetes
A supplement company, Nutrition21, today announced new published results from a 447 subject, randomized, double-blind, placebo-controlled clinical study that showed Diachrome®, a patented combination of chromium picolinate and biotin, significantly improved glycemic control in patients with poorly controlled blood sugar levels who were being treated with oral anti-diabetic medication (OADs). Patients in the treatment group showed significant improvements in glycemic control (A1C) compared with placebo (an absolute decrease of 0.54%). The greatest improvement was seen in those patients with the poorest glycemic control (baseline A1C levels equal to or greater than 10%). These patients saw an additional absolute A1C decrease of 1.76% despite the fact that they were taking one or more OAD medications.
International journal group updates guidelines on registration of clinical trials
The International Committee of Medical Journal Editors (ICMJE) updates its policy for registration of clinical trials, in an editorial appearing today on the organization’s Web site (www.icmje.org) and on the Web sites of participating journals. more
Ethanol injection helps manage bone metastasis in thyroid cancer patients
Percutaneous ethanol injection (PEI)—an injection of ethanol (alcohol) through the skin directly into a bone tumor to kill cancer cells—may be a valuable ancillary treatment for thyroid cancer patients whose cancer has spread to the bone. Japanese researchers announced these findings during the 54th Annual Meeting of SNM, the world's largest society for molecular imaging and nuclear medicine. more
Drug shows activity against brain metastases
The drug lapatinib shrank tumors and slowed progression of brain metastases in some patients with advanced breast cancer, according to results of a clinical trial being presented by Dana-Farber Cancer Institute scientists at the annual meeting of the American Society of Clinical Oncology. more
Genetic mutations identified for type of gastric cancer
Researchers have identified novel genetic mutations that are linked to hereditary diffuse gastric cancer, with these mutations being due to both independent mutational events and common ancestry, according to a study in the June 6 issue of JAMA. This study is being released early to coincide with its presentation at the annual meeting of the American Society of Clinical Oncology.
Harboring hostility may be linked to unhealthy lungs says new study
Young adults with a short temper or mean disposition also tend to have compromised lung function, says a recent study published in the journal Health Psychology, by the American Psychological Association (APA). This occurred even when asthma and smoking were ruled out as possible causes of lung dysfunction. more
Direct interconnections between nanowires and human cells
Scientists in California are reporting an advance toward one of the futuristic goals nanobiology and nanomedicine — developing technology for "wiring" together individual cells and connecting cells via nanowires to external sensors and other devices. more
© Vidyya. All rights reserved.